BBNX
Beta Bionics, Inc.
NASDAQ · USHealthcareMedical - Equipment & Services
$17.82+3.07%
Price as of Jul 20, 2026
BBNX capital
Beta Bionics, Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.03x
- Net debt / equity
- -0.09x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.11x
- Net debt / EBITDA
- 0.37x
Liquidity & coverage
- Current ratio
- 10.69x
- Quick ratio
- 9.67x
- Cash ratio
- 8.60x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $224.8M
Cash & dividend
- FCF / debt
- -8.84x
- Cash flow / debt
- -7.93x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.